
Ravinder Jain
About Ravinder Jain
Data last updated:
Ravinder Jain was a Director at Iweme Health Care Private Limited (2015–2024), Director at Iclinic Healthcare Private Limited (2013–2023) and Director at Rjc 2Ndinnings Advisory Private Limited (2017–2021), and held 3 more directorships. The companies operate in Internet, Business Services and Information Technology.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Feb 2015 | 2015 | ₹3.4 Lakh (FY 2020) | Strike Off | |
| Director | 24 Jun 2013 | 2012 | ₹28,813 (FY 2021) | Strike Off | |
| Director | 05 May 2017 | 2017 | Strike Off | ||
| Additional Director | 15 Mar 2017 | 2016 | ₹3.1 Lakh (FY 2022) | Strike Off | |
| Director | 06 Mar 2017 | 2017 | ₹1.4 Lakh (FY 2020) | Strike Off | |
| Director | 24 Nov 2016 | 2015 | ₹1.6 Lakh (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravinder Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravinder Jain
Ravinder Jain was first appointed on 24 Jun 2013 as Director at Iclinic Healthcare Private Limited. The most recent appointment on record is 05 May 2017 at Rjc 2Ndinnings Advisory Private Limited.
Ravinder Jain held 6 earlier board appointments: Iweme Health Care Private Limited (Director, 03 Feb 2015 to 19 Sep 2024); Iclinic Healthcare Private Limited (Director, 24 Jun 2013 to 17 Nov 2023); Rjc 2Ndinnings Advisory Private Limited (Director, 05 May 2017 to 01 May 2021); Wonder Mouse Technologies Private Limited (Additional Director, 15 Mar 2017 to 26 Feb 2018); Ihealthclinics Technology Private Limited (Director, 06 Mar 2017 to 01 May 2021); and 1 more.